HAS
Click for more information
0.00% 29.5¢ hastings technology metals ltd

Ann: Strategic Partner Discussions underway on Ha, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. tonio
    950 Posts.
    clock Created with Sketch.
    28/04/13
    21:14
    Post #: 11694561
    re: Ann: Strategic Partner Discussions underw... Good one Aus

    I thought HAS could also learn from Alkanes mistakes

    There is a lot of similarities

    Alkane has a reserve grade of
    35.9 MT @1.94% Zr02, 0.46% Nb2O5 ,0.89% TREO

    Hastings has a Indicated and Inferred
    36.2 MT @ 0.89% ZrO2, 0.35% Nb2O5, 0.21% TREO



    Capex, Both plants 1MT p.a.

    Alkane = $830m excl contingencies
    Hastings= $720 excl contingencies


    Annual revenue

    Alkane = $503 m
    Hastings= $482 m


    Annual EBITDA

    Alkane = $290m
    Hastings= $223m



    Tonio

    HAS Price at posting: 5.4¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add HAS (ASX) to my watchlist
(20min delay)
Last
29.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $53.34M
Open High Low Value Volume
29.5¢ 29.5¢ 29.0¢ $7.365K 25.14K

Buyers (Bids)

No. Vol. Price($)
6 102200 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 3093 1
View Market Depth
Last trade - 15.53pm 18/10/2024 (20 minute delay) ?
HAS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.